🔎 Trials Near Me

Beranda › Tumor Otak › Florida › Miami

Uji klinis Tumor Otak di Miami, FL

15 studi untuk Tumor Otak mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Menerima pesertaFase 2
  • Baptist Health Herbert Wertheim Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06991101

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Menerima pesertaFase 2
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Menerima pesertaFase 1
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • University of Miami, Miami
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Menerima pesertaFase 2
  • Baptist Health Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07428616

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • University of Miami Hospital and Clinics, Miami
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Menerima pesertaFase 3
  • Miami Cancer Institute at Baptist Health, Miami
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05317858

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Menerima peserta
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT05284643

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Menerima pesertaStudi observasional
  • Miami Cancer Institute, Baptist Health South Florida, Miami
Semua usia · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04427384

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Menerima pesertaFase 3
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT03550391

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Menerima pesertaFase 1
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06048094

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Menerima pesertaFase 1
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT04689048

Non-invasive Glioma Characterization Through Molecular Imaging

Menerima peserta
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT03684109

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Miami Cancer Institute, Miami
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

Menerima pesertaFase 2
  • Miami Cancer Institute at Baptist Health South Florida, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Des 2025 · NCT05554302

Uji klinis Tumor Otak di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.